OBJECTIVE: To search the human ob gene for mutations and evaluate their role in massive obesity. DESIGN: Direct mutation screening of the gene and case-control association study. Multivariate analyses for evaluation of differences in clinical parameters. SUBJECTS: Primary mutation screening: 24 morbidly obese subjects (body mass index (BMI) b 40 kg/m 2 ). Association study: 395 unrelated morbidly obese subjects (BMI b 40 kg/m 2 ), 121 lean, non-diabetic control individuals, 72 women of a random sample with an average BMI 32.5 kg/m 2 . RESULTS: We report the ®nding of a DNA variant in exon 1 of the human ob gene (A 7 bG substitution, base 19). This variant showed a prevalence of 62% in our study population. Association analyses under different genetic models (dominant, co-dominant, recessive) showed no signi®cant evidence for an association of this variant with BMI. However, obese individuals homozygous for the G-allele showed signi®cantly lower leptin concentrations compared to obese patients either heterozygous or homozygous for the A-allele after correction for BMI. CONCLUSION: Recent linkage studies have shown evidence for linkage of the hsob locus with obesity. Our study provides further evidence that a defect in the ob gene in linkage disequilibrium with the G-allele of exon 1 might be involved in obesity by affecting leptin concentrations.
Introduction
Obesity, which is characterised by an increase of fat content, is a common disease which has become more prevalent in developed countries over the past few years. It is well established that the extreme forms of obesity (body mass index (BMI) b 40 kg/m 2 ) are highly associated with metabolic and cardiovascular complications and represent a risk factor for early mortality. 1 Many studies have shown that obesity has a considerable inherited component. Estimations for the impact of genetic factors on obesity range from 30±75% in different populations. 2 Recent successes in the identi®cation of two loci (db and ob) in mice, 3, 4 have resulted in a dramatic gain of information about the mechanisms controlling energy metabolism and feeding behaviour both in rodents and humans.
The ob gene encodes a 16 kDa protein, secreted from white adipose tissue. In mice, it has been shown that through the binding to at least one speci®c receptor (ob-r) in the hypothalamus the ob gene product leptin triggers a reaction cascade in¯uencing feeding behaviour and metabolic rate. 5 Mice homozygous for a nonsense mutation in the gene (ob/ob) develop early onset, extreme obesity associated with hyperphagia, a decreased metabolic rate and mild hyperglycaemia. 6 Although, in contrast to the recessive mode of inheritance in ob/ob mice, human morbid obesity presents itself as a multifactorial trait it shares some features with the mouse model. We and others have recently reported evidence that the ob gene region is linked to morbid obesity (BMI b 35 kg/m 2 ) in humans. 7, 8 However, despite considerable effort, to date no mutation associated with obesity has been found in the coding region of the human ob gene (hsob, 9 ) in the family collections which reported evidence for linkage with the gene. Only recently have Montague et al, 10 described a family in which two children with extreme early onset obesity were homozygous for a frame shift mutation in codon 133 of the ob gene.
In the present study we have screened the coding region of the hsob gene and the 5 H untranslated¯anking regions including the hsob promoter for variants and evaluated their putative role in obesity by association studies.
Subjects and Methods

Patients
Twenty four massively obese individuals (with a BMI b 40 kg/m 2 ) from the families which showed the highest degree of allele sharing from our previously reported linkage studies with hsob 7 were selected for a primary mutation screening.
For association studies between a diallelic polymorphism and obesity, 395 unrelated massively obese subjects (gender ratio F/M (n), 291/104, BMI 47.4 AE 7.0 kg/m 2 , Age 44.0 AE 12.0 y, fasting leptin 57.83 AE 24.14 ng/ml) were randomly chosen from a cohort collected through a multimedia campaign in France or through the Department of Nutrition, Ho Ãtel-Dieu Hospital in Paris. In this group, 135 subjects (30%) had an overt non-insulin dependent diabetes mellitus (NIDDM) as de®ned by WHO criteria. We have recently described a 30% reduction of leptin levels and changes in other clinical parameters in massively obese subjects with severe NIDDM.
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These diabetic subjects were therefore excluded from some univariate comparisons concerning metabolic parameters. All other subjects had normal glucose tolerance (n 198) or glucose intolerance after an oral glucose tolerance test (OGGT) (n 62).
Positive Controls in the study were 121 lean (BMI`27kg/m In order to replicate a potential positive association, a population of 72 non-diabetic women was randomly recruited at the Ho Ãtel Dieu Hospital in Paris, independently of the probands collected for the study of the genetic determinants of obesity. This group consisted of randomly chosen women with a BMI over 24 kg/m 2 (mean age 43.6 AE 9.8 y, BMI 32.0 AE 5.2 (24±49), fasting leptin : 31.0 AE 12.9 (12±68) ng/ml).
To test for linkage disequilibrium, a transmissiondisequilibrium test (TDT) was performed in the collection of 101 families with morbid obesity described earlier. 7 Leptin was measured for all individuals in the fasting state by radioimmunoassay (RIA) using reagents supplied by Linco Research Inc (St Louis, MO, USA) as described earlier.
Mutation screening
Primers were designed to amplify the coding region containing exons 2 and 3 of the hsob gene as well as the complete promoter including the untranslated ®rst exon of the gene (Table 1) . PCR was carried out as follows: Denaturation at 94 C for 5 min followed by 30 cycles of 94 C for 20 s, fragment speci®c annealing temperature (Table 1) for 15 s and 72 C for 20 s and a ®nal extension step of 72 C for 5 min. PCR products were controlled on agarose gels and puri®ed through p60 columns (BioRad Laboratories., Hercules, USA) to eliminate unincorporated nucleotides and primers. The puri®ed products were then directly sequenced using the ABI dye terminator sequencing kit and following the standard protocol (Applied Biosystems Inc, Foster City, USA). Fragments were sequenced on both strands and the sequence determined on an automated ABI sequencer. The obtained sequences were compared with the published sequence for the human obgen (hsob) gene (GenBank NID: g1071651-53) and the sequence from a non-obese reference individual.
For the detection of an exon 1 variant of human obgen (hsob) by PCR-RFLP, DNA was ampli®ed as described above. Ten microliters of PCR Product were incubated with 2U of restriction endonuclease Nsp BII (Amersham Life Science, UK) with incubation buffer L 1% BSA in a total volume of 15 ml at 37 C overnight. The digestion products were stained with ethidium bromide and analysed in 4% MetaPhor gels (FMC Chemicals, USA). DNA from individuals with known genotype served as positive controls for the digestion reaction. Additionally, genotypes from 12 randomly drawn subjects were veri®ed by direct sequencing.
Statistics
Contingency table chi-square tests were used to compare genotype frequencies and other qualitative data. The Shapiro-Wilk W test was used to test the gaussian distribution of all clinical and biological parameters. Skewed variables were log-transformed for analysis of variance (ANOVA). Data are expressed as mean AE standard deviation (s.d.).
The relationship between the ob gene variant BMI (or body fat) and serum leptin were studied according to a least square model of analysis. Multiple regression analysis was also performed to test for possible relationships between the exon 1 variant of the hsob gene and clinical parameters. Statistics were per- 13 were performed to test for linkage disequilibrium between the G-allele and obesity in our family sample. Both tests are implemented in the program tdtlikena from Terwilliger. The classical test compares the frequency with which a suspected allele is transmitted to affected offspring to the frequency of non-transmission. In the case of our study the P value was computed from a binomial distribution which is better adapted to small sample sizes than the classical chi-square estimation. In addition a likelihood ratio test based method, which, considering both alleles jointly, estimates the probability lambda to transmit one of the alleles to affected offspring by maximum likelihood, was used.
Results
Upon sequencing of the whole coding region (exon 2 and 3) of the hsob gene, no sequence variants were found in 24 massively obese individuals. However, about 62% of the probands were either homo-or heterozygous for a single base transition from A±G at nucleotide position 19 of the untranslated exon 1 of the hsob gene compared to the published sequence ( Figure 1 ). The base exchange creates a new recognition site for the restriction endonuclease, Nsp BII. For an association study, a second set of individuals were therefore screened for the presence or absence of the transition by PCR-RFLP.
An association study genotyped 398 morbidly obese and 121 lean control individuals. The results of the association study are summarised in Table 2a±c . Several genetic models were tested for association between the exon 1 variant and morbid obesity. Treating the genotypes as a trichotomy (co-dominant) model, showed no evidence for an association between genotype and BMI, neither did the analyses assuming a dominant or recessive mode of inheritance.
We further evaluated if the exon 1 variant was associated with any clinical or biological parameters in the morbidly obese group. Subjects homozygous for the G allele had signi®cantly lower serum leptin concentrations (51.5 AE 24 ng/ml) compared to subjects with the AG (60.0 AE 26 ng/ml) or AA genotypes (61.0 AE 22.0 ng/ml; P 0.02, BMI and gender adjusted data). When grouping subjects with the AG and AA genotypes (recessive model), the association became even stronger (P 0.006). Gender, age, BMI, fasting glucose and fasting insulinaemia were not signi®-cantly different between massively obese individuals homozygous for the GG genotype and the AG or AA genotype carriers. All analyses were also repeated excluding all individuals with overt NIDDM as their severe hyperglycaemic state might in¯uence the leptin concentration, thereby biasing the results. 11 The results obtained were similar to the ones obtained for the whole group. Individuals homozygous for the GG genotype had signi®cantly lower leptin concentrations (53.5 AE 24.0 ng/ml) compared to individuals either heterozygous or homozygous for the AA genotype (66 AE 24.0 ng/ml; P 0.001, BMI and gender adjusted data) ( Table 3 ). Analyses were also carried out separately for men and women because of the well established gender difference of leptin concentrations. Non diabetic obese women, homozygous for the G allele of the exon 1 variant presented signi®cantly lower fasting leptin concentrations (57 AE 23.7 ng/ml) com- pared to subjects being either heterozygous (AG) or homozygous for the A allele (66 AE 27.5 ng/ml, P 0.03 BMI adjusted). The results in the male group were nonsigni®cant under all models (data not shown). However, this group consisted of only 36 individuals.
To determine whether the association between fasting leptin concentrations and the exon 1 polymorphism, found in the massively obese group, was independent of the other tested factors, particularly gender, we performed a multivariate analysis in the whole group of morbidly obese subjects. Several parameters including gender (F/M), age, BMI, and fasting glucose and the exon 1 variant (GG vs AG AA) genotypes were introduced into a standard least square model of analysis (after logarithmic transformation of the quantitative variables). This analysis showed a signi®cant inverse association between being homozygous for the G allele and leptin (F 9.04, P 0.003), con®rming that the variant was associated with leptin, independently of the other factors.
In order to replicate our ®rst ®ndings in an independent population, we evaluated a possible association of any of the genotypes with leptin in the second set of 72 women. Distribution of the genotypes in this group were similar to the other tested populations (n 29 GG (40%), n 29 AG (40%) and n 14 AA (19%), respectively). The association study showed a somewhat higher BMI (34.5 AE 5.0 kg/m 2 compared to 31.6 AE 6.0, P 0.02) in the 29 women homozygous for the G allele when compared to those either heterozygous (AG) or homozygous and for the A allele. Despite the somewhat higher BMI, leptin concentrations were about 15% lower in the group of women with the GG genotype (P 0.03 after adjustment for BMI, P 0.05 after adjustment for fat) ( Table 4) .
To further consolidate our earlier linkage results we performed a classical TD 12 test as well as a likelihood Human ob gene and low leptin levels J Hager et al approach as proposed by Terwilliger. 13 A number of families were not informative for the TDT for the lack of parental genotype information, or because both parents were homozygous for either the A or the G allele (65%). The frequencies of the two alleles were G 44 % and A 56%, respectively in the family sample population. The G-allele of the bi-allelic polymorphism was transmitted 12 times and nottransmitted three times to affected offspring (P 0.03) in our sample. Also, using the likelihood ratio based test method, as described in material and methods, the TDT gave evidence for linkage disequilibrium of the variant with obesity (P 0.02).
Discussion
One approach to dissect the genetic mechanisms underlying complex diseases, is the use of well de®ned animal models where the genetic and environmental backgrounds are well controlled. Genetic susceptibility loci derived from such models might potentially also be good candidates for the human condition. The human homologue of the mouse ob gene, mutations in which lead to a recessively, autosomally inherited form of extreme obesity in mice, is such a candidate. Using human phenotypes showing some similarities to the mouse model (extreme, morbid obesity with a BMI b 35 kg/m 2 ) we and other research groups were able to show some evidence for linkage of the human ob gene locus with high BMI suggesting a role of this gene in humans. 7, 8 However, unlike the animal models, no mutations were found in the coding region of the gene, rendering the interpretation of the linkage results dif®cult. 9 Although Montague et al 10 have recently described a mutation of hsob in two very obese children, our results described in the present study indicate that mutations in the hsob gene are unlikely to be a common cause of human obesity, even for this extreme phenotype. However, we found that a variant in exon 1 of the gene was associated with low leptin levels in massively obese individuals and in a cohort of randomly chosen Caucasian women, as would be expected in individuals with an hsob gene defect. Although leptin levels are generally high in obese individuals and are correlated to increases in BMI, several studies have shown that a signi®cant proportion of obese individuals actually have relatively low leptin levels after correction for BMI.
14 It could be hypothesised that leptin levels in those massively obese individuals are not high enough to allow a normal metabolic control of energy expenditure and food intake. In this respect, Ravussin et al 15 have shown that in Pima Indians (a population with a high genetic risk for massive obesity), subjects with relatively low leptin levels are more likely to gain weight than others.
Association studies can be powerful tools to support the involvement of a gene in a disease. As association is detectable over a relatively small distance (usuallỳ 2 cM in a heterogeneous population 16 ) it gives far more direct evidence that a gene may play a role in the disease aetiology than do linkage analyses. On the other hand case-control studies have sometimes led to false conclusions mainly because of population admixture. Therefore, we could not exclude that our association data between ob and morbid obesity are due to population sample biases, even though the controls are from the same collection sources.
Linkage TDTs in families, where the transmission of an allele to affected offspring is compared to nontransmission, circumvents the problems hampering case-control studies. Carrying out TDTs our sample shows some evidence for an excess transmission of the G-allele of the ob gene polymorphism to affected offspring in the tested families. Although our sample size is relatively small, our present results provide some evidence that this variant is in linkage disequlibrium with morbid obesity. It should be strengthened here that in the case where more than one offspring per family is included, as in this study, the TDT is no longer valid for association, but rather tests linkage between the marker allele and the phenotype. 17 However, our data also suggest that homozygosity for the G-allele may increase the risk for obesity, by lowering leptin values. This homozygous genotype could therefore (together with the other indications like linked marker haplotypes) serve as a marker for the selection of obese individuals for screening the ob gene, especially the promoter and as yet unscreened intronic regions. But, it has to be emphasised that the role of the ob gene in the development of human obesity seems to be small. A fact also emphasised by the rarity of mutations that have been found in the gene of obese individuals.
In conclusion, screening of the whole coding region and 5
H and 3 H¯a nking regions revealed a single A/G variant at position 19 of the untranslated exon 1 of the hsob gene. This base exchange is associated with lower leptin levels in two Caucasian populations and analysis of the transmission of the variant in families with obesity, shows some evidence excess of transmission of the G allele to affected offspring. The result emphasises our earlier linkage ®ndings and gives additional evidence for the involvement of this locus in morbid obesity. However, the results also show that the ob gene is not a major player in the development of human obesity.
